Treatment of Hyperuricemia in Patients With Heart Failure

• Status: Completed
• Trial end date: 2005-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The study aims to assess (I) the contribution of UA itself to the CHF pathophysiology and (II) to test the effect of lowering UA by uricosuric treatment in CHF.

• Phase: Phase 4

Details

• Lead Sponsor: Tottori University Hospital
• Treatments: Benzbromarone

Criteria

Inclusion Criteria:

• chronic heart failure

• hyperuricemia

Exclusion Criteria:

• renal dysfunction (Cr > 2.0 mg/dl)

• under treatment with anti-diabetic agents